A candidate gene study was conducted on 10 established type II diabetes genes and 45 genes associated with autoimmune diseases, including type I diabetes (T1D), in a maximum of 1410 affected sib-pair families assembled by the Type I Diabetes Genetics Consortium. Associations at P values o10 À3 were found for three known T1D regions at chromosomes 4q27, 12q13.2 and 12q24.13 (http://www.T1DBase.org). Support was obtained for a newly identified T1D candidate locus on chromosome 12q13.3-12q14.1 (rs1678536/KIF5A: P ¼ 8.1 Â 10
Introduction
The advent of genome-wide association studies has highlighted the commonality and differences between diseases. Genes found to be associated in one disease are now routinely genotyped in related diseases, providing a more focused and often more informative candidate gene approach.
1,2 A candidate gene study was performed using a panel of 216 SNPs from 10 known T2D loci (including HHEX and SLC30A8), 126 SNPs from 5 known T1D regions (including CTLA4 and IL2) and 239 SNPs from 40 known other autoimmune disease regions (including IL23R and PADI4). Although T1D and T2D are considered etiologically distinct, characterized by autoimmune destruction of the pancreatic b cells and by impaired b cell function, respectively, T2D loci were included in the study as they may share a common pathophysiological etiology, suggested by the similarities in their clinical manifestation. 3 The five known T1D loci were included for further confirmation. All SNPs were genotyped in a maximum of 1410 T1D affected sib-pair families assembled by the Type I Diabetes Genetics Consortium (T1DGC), providing 2198 parent-child trios. A complete list of SNPs, genes and regions is provided in Supplementary Table 1 .
Results
A total of 581 SNPs was selected from T2D genes related to b-cell function, T1D and other autoimmune candidate genes and genotyped at the Broad Institute of Harvard/ MIT in Cambridge, MA, USA (http://www.broad.mit. edu/) using the Illumina Golden Gate platform. In addition to the standard sample and SNP quality control, we visually inspected the SNP signal intensity plots for each of the family groups (see accompanying paper 4 ), resulting in 334 SNPs that passed quality control (Supplementary Table 1 
À3
) and SLC30A8 on 8q24.11 (P ¼ 1.6 Â 10
). Recent studies of SLC30A8 have identified an association of T2D with the non-synonymous SNP, rs13266634 (Arg325Trp), an SNP also genotyped in this study. This SNP has also been reported to determine ZnT8 autoantibody specificity in T1D; 6 however, no association with T1D was found with this SNP in this study of T1D affected sib-pair families (data not shown) in agreement with an earlier study of 7680 British T1D cases and 7200 controls. 7 Similarly, the most strongly associated CDKAL1 SNP with T2D was not associated with T1D in this large British case-control study. 7 In addition, some evidence of association with T1D (Table 1) was found for rs231727 in CTLA4 on chromosome 2q33.
), a known T1D region; 7 rs1678536 in KIF5A on 12q13.3 (P ¼ 8.11 Â 10
) and rs701008 in AGAP2 on 12q14.1 (P ¼ 2.5 Â 10
). The KIF5A and AGAP2 SNPs are not independently associated with T1D: using logistic regression, adding rs1678536/KIF5A to rs701008/AGAP2 gave P ¼ 0.37 and rs701008/AGAP2 to rs1678536/KIF5A gave P ¼ 0.08. The two SNPs are 138 kb apart and in the same linkage disequilibrium block (D 0 ¼ 0.78 and r 2 ¼ 0.42 in parents). 7 The associated 12q13.3-q14.1 region is approximately 1.6 Mb. Nevertheless, the association of the rs1678536/KIF5A and rs701008/AGAP2 SNPs is independent of the established ERBB3/12q13.2-q13.3 region:
8 using logistic regression, adding rs11171747/ ERBB3 (most associated SNP found in this study) to rs1678536/KIF5A gave P ¼ 1.4 Â 10
and adding rs1678536/KIF5A to rs11171747/ERBB3 gave P ¼ 7.3 Â 10
. KIF5A is about 2 Mb centromeric of ERBB3 with a single recombination hotspot between these genes. 
Discussion
In addition to the previously reported T1D-associated ERBB3/12q13.2-q13.3 region, 5 we provide evidence of an independent T1D locus within the 12q13.3-q14.1 region, which contains 47 protein-coding genes, including KIF5A, AGAP2, PIP4K2C and also the vitamin D-associated gene CYP27B1, which has been reported to show some evidence of an association with T1D. 9 However, rs1678542/KIF5A (an SNP associated with rheumatoid arthritis) 10 and rs10877012/CYP27B1 are not independently associated with T1D in 7455 cases and 9089 controls: using logistic regression, adding rs1678542/KIF5A to rs10877012/ CYP27B1 gave P ¼ 0.018 and rs10877012/CYP27B1 to rs1678542/KIF5A gave P ¼ 0.10. The 12q13.3-q14.1 region has been earlier associated with rheumatoid arthritis (rs1678542/KIF5A) 10 and most recently with T1D in 8010 cases and 9733 controls (rs1678542/KIF5A, P ¼ 3.0 Â 10
À4
; OR ¼ 0.92, 95% CI ¼ 0.88-0.96).
2 Hence, we have obtained further support for the 12q13.3-q14.1 region in T1D affected sib-pair families. As this region contains 47 protein-coding genes, further sequencing and genotyping will be required to ascertain the contribution of these genes to T1D. We found no convincing evidence of commonality between type I and type II diabetes.
Materials and methods

Subjects
The DNA samples were genotyped at the Broad Institute of Harvard/MIT in Cambridge, MA, USA (http:// www.broad.mit.edu/). The samples were assembled by the T1DGC and consist of affected sib-pair families of two parents and two affected offspring. The families were obtained from nine cohorts: Diabetes UK (DUK), Human Biological Data Interchange (HBDI), T1DGC Asia Pacific (AP) Network, T1DGC European (EUR) Network, T1DGC United Kingdom (UK) Network, T1DGC North America (NA) Network, Joslin (JOS) Diabetes Center, Sardinia (SAR) and Denmark (DAN). The AP, EUR, NA and UK collections were newly recruited by the T1DGC, whereas the remainder where part of established collections; 2074 families had at least 1 member who passed sample quality control, 1410 families provided 2798 parent-child trios.
SNP selection
A total of 581 SNPs were selected from T2D genes related to b-cell function, recent T1D and other autoimmune candidate genes (Table 1 ; www.T1DBase.org). SNPs were genotyped using the Illumina Golden Gate platform at the Broad Institute of Harvard/MIT in Cambridge, MA, USA (http://www.broad.mit.edu/). In addition to standard sample and SNP quality control, SNP signal intensity plots for each of the family groups were visually inspected (see accompanying paper 4 ). This process provided 334 SNPs with well-separated signal clouds-148 of 239 SNPs from autoimmune disease regions, 114 of 216 SNPs from T2D regions and 72 of 126 SNPs from T1D regions. Genotype signal intensity cluster plots are available in T1DBase. 8 
Statistics
All analyses were carried out in the R statistical environment using the snpMatrix package from the bioConductor project. 11 Family groups were analyzed using the transmission/disequilibrium test configured as a score test. The scores and their variances were summed over family groups and genotyping centers to pool information.
